Design Considerations for Cell and Gene Therapy Facilities
Posted byBecky Scheible
As the life science industry moves from conventional biologics to advanced therapy medicinal products (ATMPs) such as cell and gene therapies, facilities must evolve to accommodate these new processes. Developers and biotechs alike may be wondering how to adapt their existing spaces and what an ideal facility looks like. FPBA’s Executive Vice President Andy Darragh provides insight on cell and gene therapy facility design below.
Want to learn more or speak to someone at FPBA about cell and gene therapy facility design? Get in touch with us using the below form, and we will respond promptly.